CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Understand factors that indicate long-term growth potential in crypto coins and how to select those with staying power.
27,742 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...
When a mid-size firm makes a bold move into quantum tech, the market watches closely. This piece breaks down what Try...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
As markets wobble, traders watch RSI and other momentum tools to spot oversold stocks. This piece explains what overs...
A year after XRP surged to $3.65, ripple (xrp) peaked $3.65 remains a milestone. Today, the token is far lower as reg...
A wave of fresh analyst calls is shaping trading as Friday’s Wall Street topics include Amgen, Etsy, Eldorado Gold, G...
This article breaks down United Parks PRKS 2026 Q1 earnings, highlighting revenue growth, margins, and the drivers sh...
Real estate cycles linger, but today’s price pressures aren’t a carbon copy of 2008. Learn how Ken McElroy analyzes c...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
Forum Energy's latest earnings reveal how the company balances growth with cash flow in volatile markets. This guide ...
Q1 2026 earnings transcripts reveal more than quarterly numbers. Explore how guidance, margin trends, and management ...